{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T20:07:00Z","timestamp":1790366820485,"version":"4.1.0"},"reference-count":60,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Revue de M\u00e9decine Interne"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.revmed.2024.03.006","type":"journal-article","created":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T17:29:21Z","timestamp":1711042161000},"page":"488-497","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Fasciite \u00e0 \u00e9osinophiles\u00a0: actualit\u00e9s physiopathologiques et nouvelles voies th\u00e9rapeutiques"],"prefix":"10.1016","volume":"45","author":[{"given":"S.","family":"Knapp","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Bolko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Servettaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Didier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.revmed.2024.03.006_bib0305","first-page":"70","article-title":"Diffuse fasciitis with eosinophilia: a new syndrome?","volume":"88","author":"Shulman","year":"1975","journal-title":"Trans Assoc Am Physicians"},{"key":"10.1016\/j.revmed.2024.03.006_bib0310","first-page":"525","article-title":"Proceedings: eosinophilic fasciitis. Report of six cases of a newly recognized scleroderma-like syndrome","volume":"18","author":"Rodnan","year":"1975","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2024.03.006_bib0315","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.jaad.2017.05.018","article-title":"Long-term outcome of eosinophilic fasciitis: a cross-sectional evaluation of 35\u00a0patients","volume":"77","author":"Mertens","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.revmed.2024.03.006_bib0320","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1111\/1346-8138.14160","article-title":"Diagnostic criteria, severity classification and guidelines of eosinophilic fasciitis","volume":"45","author":"Jinnin","year":"2018","journal-title":"J Dermatol"},{"key":"10.1016\/j.revmed.2024.03.006_bib0325","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.autrev.2014.01.019","article-title":"Diagnosis and classification of eosinophilic fasciitis","volume":"13","author":"Pinal-Fernandez","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.revmed.2024.03.006_bib0330","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.revmed.2015.08.002","article-title":"[Eosinophilic fasciitis (Shulman's disease): diagnostic and therapeutic review]","volume":"36","author":"S\u00e8ne","year":"2015","journal-title":"Rev Med Interne"},{"issue":"5","key":"10.1016\/j.revmed.2024.03.006_bib0335","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.jaad.2022.08.026","article-title":"Cluster analysis reveals eosinophilia and fibrosis as poor prognostic markers in 128\u00a0patients with eosinophilic fasciitis","volume":"87","author":"Chaigne","year":"2022","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.revmed.2024.03.006_bib0340","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1016\/j.jaad.2021.05.030","article-title":"Drug-induced eosinophilic fasciitis: a dual pharmacovigilance analysis","volume":"86","author":"Teboul","year":"2022","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.revmed.2024.03.006_bib0345","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1634\/theoncologist.2019-0508","article-title":"Eosinophilic fasciitis following checkpoint inhibitor therapy: four cases and a review of literature","volume":"25","author":"Chan","year":"2020","journal-title":"Oncologist"},{"key":"10.1016\/j.revmed.2024.03.006_bib0350","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1007\/s40744-020-00246-z","article-title":"Immune checkpoint inhibitor-associated scleroderma-like syndrome: a report of a pembrolizumab-induced \u201ceosinophilic fasciitis-like\u201d case and a review of the literature","volume":"7","author":"Salamaliki","year":"2020","journal-title":"Rheumatol Ther"},{"key":"10.1016\/j.revmed.2024.03.006_bib0355","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0049-0172(88)90008-X","article-title":"Eosinophilic fasciitis: clinical spectrum and therapeutic response in 52\u00a0cases","volume":"17","author":"Lakhanpal","year":"1988","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.revmed.2024.03.006_bib0360","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/MD.0b013e3182899e78","article-title":"Severe aplastic anemia associated with eosinophilic fasciitis: report of 4\u00a0cases and review of the literature","volume":"92","author":"de Masson","year":"2013","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.revmed.2024.03.006_bib0365","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.anai.2020.08.395","article-title":"Eosinophilic fasciitis in common variable immunodeficiency with hypereosinophilia","volume":"126","author":"Daniels","year":"2021","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.revmed.2024.03.006_bib0370","doi-asserted-by":"crossref","first-page":"e101","DOI":"10.1111\/jdv.13819","article-title":"Efficacy of eculizumab against eosinophilic fasciitis associated with paroxysmal nocturnal haemoglobinuria","volume":"31","author":"Frumholtz","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.revmed.2024.03.006_bib0375","doi-asserted-by":"crossref","first-page":"183","DOI":"10.5114\/pjp.2016.61456","article-title":"Shulman disease (eosinophilic fasciitis) in X-linked agammaglobulinemia","volume":"67","author":"Pituch-Noworolska","year":"2016","journal-title":"Pol J Pathol"},{"key":"10.1016\/j.revmed.2024.03.006_bib0380","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s42358-022-00262-3","article-title":"Graft versus host disease-related eosinophilic fasciitis: cohort description and literature review","volume":"62","author":"Hidalgo Calleja","year":"2022","journal-title":"Adv Rheumatol"},{"key":"10.1016\/j.revmed.2024.03.006_bib0385","first-page":"1383","article-title":"Rheumatoid arthritis with eosinophilic fasciitis and pure red cell aplasia","volume":"16","author":"Markusse","year":"1989","journal-title":"J Rheumatol"},{"key":"10.1016\/j.revmed.2024.03.006_bib0390","first-page":"001722","article-title":"Atypical presenting symptoms of acute onset acquired haemophilia with eosinophilic fasciitis","volume":"7","author":"Nakakubo","year":"2020","journal-title":"Eur J Case Rep Intern Med"},{"key":"10.1016\/j.revmed.2024.03.006_bib0395","doi-asserted-by":"crossref","first-page":"e13641","DOI":"10.1111\/dth.13641","article-title":"Eosinophilic fasciitis associated with generalized morphea and IgA nephropathy","volume":"33","author":"Luo","year":"2020","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.revmed.2024.03.006_bib0400","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1007\/s10067-008-0912-2","article-title":"Long-term remission by cyclosporine in a patient with eosinophilic fasciitis associated with primary biliary cirrhosis","volume":"27","author":"Tahara","year":"2008","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.revmed.2024.03.006_bib0405","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1001\/jamadermatol.2015.3648","article-title":"Epidemiology and treatment of eosinophilic fasciitis: an analysis of 63\u00a0patients from 3\u00a0tertiary care centers","volume":"152","author":"Wright","year":"2016","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.revmed.2024.03.006_bib0410","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1093\/rheumatology\/ker366","article-title":"Eosinophilic fasciitis (Shulman disease): new insights into the therapeutic management from a series of 34\u00a0patients","volume":"51","author":"Lebeaux","year":"2012","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.revmed.2024.03.006_bib0415","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/1756-185X.13770","article-title":"Baseline characteristics and long-term outcomes of eosinophilic fasciitis in 89\u00a0patients seen at a single center over 20\u00a0years","volume":"23","author":"Mango","year":"2020","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.revmed.2024.03.006_bib0420","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/1756-185X.12499","article-title":"Eosinophilic fasciitis: clinical characteristics and response to methotrexate","volume":"18","author":"Berianu","year":"2015","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.revmed.2024.03.006_bib0425","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1007\/s10067-014-2777-x","article-title":"The use of an elevated aldolase in diagnosing and managing eosinophilic fasciitis","volume":"34","author":"Nashel","year":"2015","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.revmed.2024.03.006_bib0430","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1007\/s10067-006-0525-6","article-title":"Eosinophilic fasciitis: report of two cases and a systematic review of the literature dealing with clinical variables that predict outcome","volume":"26","author":"Endo","year":"2007","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.revmed.2024.03.006_bib0435","doi-asserted-by":"crossref","first-page":"e227","DOI":"10.1111\/ajd.12973","article-title":"Eosinophilic fasciitis associated with myositis: report of four cases and review of the literature","volume":"60","author":"Liu","year":"2019","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.revmed.2024.03.006_bib0440","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1378\/chest.100.5.1453","article-title":"Extrapulmonary thoracic restriction (hidebound chest) complicating eosinophilic fasciitis","volume":"100","author":"Chalker","year":"1991","journal-title":"Chest"},{"key":"10.1016\/j.revmed.2024.03.006_bib0445","doi-asserted-by":"crossref","first-page":"5452","DOI":"10.1038\/s41598-023-32678-2","article-title":"Clinical characteristics and risk factors of patients with eosinophilic fasciitis associated with pleural effusion","volume":"13","author":"Chen","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.revmed.2024.03.006_bib0450","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/j.1365-2133.2004.06062.x","article-title":"Serum levels of tissue inhibitor of metalloproteinase-1\u00a0and 2\u00a0in patients with eosinophilic fasciitis","volume":"151","author":"Jinnin","year":"2004","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.revmed.2024.03.006_bib0455","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.diii.2014.06.018","article-title":"Eosinophilic fasciitis: typical abnormalities, variants and differential diagnosis of fasciae abnormalities using MR imaging","volume":"96","author":"Kirchgesner","year":"2015","journal-title":"Diagn Interv Imaging"},{"key":"10.1016\/j.revmed.2024.03.006_bib0460","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/1756-185X.14099","article-title":"Musculoskeletal ultrasound as a diagnostic tool for eosinophilic fasciitis and correlation with magnetic resonance imaging findings","volume":"24","author":"Narula","year":"2021","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.revmed.2024.03.006_bib0465","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.jbspin.2014.07.001","article-title":"Fluorodeoxyglucose positron emission tomography in eosinophilic fasciitis","volume":"81","author":"Marie","year":"2014","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.revmed.2024.03.006_bib0470","first-page":"493","article-title":"Eosinophilic fasciitis. A pathologic study of twenty cases","volume":"96","author":"Barnes","year":"1979","journal-title":"Am J Pathol"},{"key":"10.1016\/j.revmed.2024.03.006_bib0475","first-page":"1811","article-title":"In situ immunophenotype of the inflammatory infiltrate in eosinophilic fasciitis","volume":"30","author":"Toquet","year":"2003","journal-title":"J Rheumatol"},{"key":"10.1016\/j.revmed.2024.03.006_bib0480","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1182\/blood.V83.10.2759.2759","article-title":"The idiopathic hypereosinophilic syndrome","volume":"83","author":"Weller","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2024.03.006_bib0485","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.clindermatol.2018.04.006","article-title":"Eosinophilic fasciitis: current concepts","volume":"36","author":"Fett","year":"2018","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.revmed.2024.03.006_bib0490","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1002\/ajh.25495","article-title":"POEMS syndrome: 2019\u00a0update on diagnosis, risk-stratification, and management","volume":"94","author":"Dispenzieri","year":"2019","journal-title":"Am J Hematol"},{"key":"10.1016\/j.revmed.2024.03.006_bib0495","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1007\/s12016-017-8625-4","article-title":"Cutaneous manifestations of scleroderma and scleroderma-like disorders: a comprehensive review","volume":"53","author":"Ferreli","year":"2017","journal-title":"Clinic Rev Allerg Immunol"},{"key":"10.1016\/j.revmed.2024.03.006_bib0500","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1002\/art.1780251006","article-title":"Circulating immune complexes in eosinophilic fasciitis","volume":"25","author":"Seibold","year":"1982","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2024.03.006_bib0505","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1136\/ard.62.2.190","article-title":"Circulating soluble CD40\u00a0ligand in patients with eosinophilic fasciitis","volume":"62","author":"Jinnin","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.revmed.2024.03.006_bib0510","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1093\/rheumatology\/keac526","article-title":"Eosinophilic fasciitis (Shulman syndrome)-recognition of the histological spectrum allows for new insights into possible pathomechanisms","volume":"62","author":"Pehl","year":"2023","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.revmed.2024.03.006_bib0515","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/nri.2017.90","article-title":"Type 2\u00a0immunity in tissue repair and fibrosis","volume":"18","author":"Gieseck","year":"2018","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.revmed.2024.03.006_bib0520","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1001\/archderm.1990.01670290057008","article-title":"Eosinophilic fasciitis: increased collagen production and type I procollagen messenger RNA levels in fibroblasts cultured from involved skin","volume":"126","author":"K\u00e4h\u00e4ri","year":"1990","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.revmed.2024.03.006_bib0525","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/S1081-1206(10)61832-7","article-title":"Cytokine abnormalities in a patient with eosinophilic fasciitis","volume":"90","author":"Dziadzio","year":"2003","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.revmed.2024.03.006_bib0530","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s00018-013-1457-3","article-title":"Cytokine functions of TIMP-1","volume":"71","author":"Ries","year":"2014","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.revmed.2024.03.006_bib0535","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1111\/1346-8138.12563","article-title":"Serum levels of matrix metalloproteinase-13\u00a0in patients with eosinophilic fasciitis","volume":"41","author":"Asano","year":"2014","journal-title":"J Dermatol"},{"key":"10.1016\/j.revmed.2024.03.006_bib0540","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1136\/ard.55.12.935","article-title":"Serum and synovial fluid levels of interleukin-5\u00a0in a patient with eosinophilic fasciitis","volume":"55","author":"Nishiya","year":"1996","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.revmed.2024.03.006_bib0545","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1136\/annrheumdis-2021-eular.3542","article-title":"Pos0429\u00a0interleukin-4\u00a0activates eosinophils and Ccr3-positive T helper cells migration to fascia and promotes fibrosis in eosinophilic fasciitis","volume":"80","author":"Hosonuma","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.revmed.2024.03.006_bib0550","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1111\/cup.12947","article-title":"Th1- and Th17-polarized immune infiltrates in eosinophilic fasciitis\u00a0\u2013\u00a0a potential marker for histopathologic distinction from morphea","volume":"44","author":"Moy","year":"2017","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.revmed.2024.03.006_bib0555","first-page":"75","article-title":"Analysis of leukemia inhibitory factor, type 1\u00a0and type 2\u00a0cytokine production in patients with eosinophilic fasciitis","volume":"28","author":"Viallard","year":"2001","journal-title":"J Rheumatol"},{"key":"10.1016\/j.revmed.2024.03.006_bib0560","doi-asserted-by":"crossref","first-page":"a016295","DOI":"10.1101\/cshperspect.a016295","article-title":"IL-6\u00a0in inflammation, immunity, and disease","volume":"6","author":"Tanaka","year":"2014","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.1016\/j.revmed.2024.03.006_bib0565","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jaad.2020.11.009","article-title":"Trunk involvement and peau d\u2019orange aspect are poor prognostic factors in eosinophilic fasciitis (Shulman's disease): a multicenter retrospective study of 119\u00a0patients","volume":"88","author":"Zuelgaray","year":"2023","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.revmed.2024.03.006_bib0570","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.jaad.2008.07.042","article-title":"Ultraviolet A phototherapy for sclerotic skin diseases: a systematic review","volume":"59","author":"Kroft","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.revmed.2024.03.006_bib0575","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.transci.2015.02.005","article-title":"Extracorporeal photopheresis for the treatment of autoimmune diseases","volume":"52","author":"Adamski","year":"2015","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.revmed.2024.03.006_bib0580","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.jaad.2021.03.089","article-title":"Biologic treatment outcomes in refractory eosinophilic fasciitis: a systematic review of published reports","volume":"86","author":"Mufti","year":"2022","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.revmed.2024.03.006_bib0585","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.alit.2020.10.001","article-title":"The efficacy of off-label IL-5-modulating treatment in rare eosinophil-mediated diseases","volume":"70","author":"Shamriz","year":"2021","journal-title":"Allergol Int"},{"key":"10.1016\/j.revmed.2024.03.006_bib0590","first-page":"1721","article-title":"Mepolizumab for refractory eosinophilic fasciitis: a retrospective analysis from two tertiary care centres","volume":"41","author":"Sanchez-Melendez","year":"2023","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.revmed.2024.03.006_bib0595","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1111\/ced.15379","article-title":"Dupilumab for treatment of eosinophilic fasciitis","volume":"47","author":"Xia","year":"2022","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.revmed.2024.03.006_bib0300","doi-asserted-by":"crossref","first-page":"107666","DOI":"10.1016\/j.pharmthera.2020.107666","article-title":"TGF\u03b2\u00a0\u2013\u00a0directed therapeutics: 2020","volume":"217","author":"Teicher","year":"2021","journal-title":"Pharmacol Ther"}],"container-title":["La Revue de M\u00e9decine Interne"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866324000869?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866324000869?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,10]],"date-time":"2024-08-10T17:33:47Z","timestamp":1723311227000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0248866324000869"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":60,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S0248866324000869"],"URL":"https:\/\/doi.org\/10.1016\/j.revmed.2024.03.006","relation":{},"ISSN":["0248-8663"],"issn-type":[{"value":"0248-8663","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fasciite \u00e0 \u00e9osinophiles\u00a0: actualit\u00e9s physiopathologiques et nouvelles voies th\u00e9rapeutiques","name":"articletitle","label":"Article Title"},{"value":"La Revue de M\u00e9decine Interne","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.revmed.2024.03.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Soci\u00e9t\u00e9 Nationale Fran\u00e7aise de M\u00e9decine Interne (SNFMI). Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}